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Abstract 
Background: Stroke survivors with severe upper limb disability need opportunities to engage 
in task-oriented practice to achieve meaningful recovery.  
Objective: To compare the effect of SMART Arm training, with or without outcome-
triggered electrical stimulation to usual therapy, on arm function for stroke survivors with 
severe upper limb disability undergoing inpatient rehabilitation.  
Methods: A prospective, multicentre, randomised controlled trial was conducted with three 
parallel groups, concealed allocation, assessor blinding and intention-to-treat analysis. Fifty 
inpatients within four months of stroke with severe upper limb disability were randomly 
allocated to 60 mins/day, 5 day a week for 4 weeks of: (1) SMART Arm with outcome-
triggered electrical stimulation and usual therapy, (2) SMART Arm alone and usual therapy, 
or (3) usual therapy. Assessment occurred at baseline (0-weeks), post-training (4-weeks), and 
follow-up (26- and 52-weeks). The primary outcome measure was Motor Assessment Scale 
Item 6 (MAS6) at post-training.  
Results: All groups demonstrated a statistically (P < 0.001) and clinically significant 
improvement in arm function at post-training (MAS6 change ≥1 point) and at 52-weeks 
(MAS6 change ≥2 points). There were no differences in improvement in arm function 
between groups (P = 0.367). There were greater odds of a higher MAS6 score in SMART 
Arm groups as compared to usual therapy alone post-training (SMART Arm stimulation 
GenOR = 1.47, 95%CI 1.23 to 1.71) and at 26-weeks (SMART Arm alone GenOR = 1.31, 
95% CI 1.05 to 1.57).  
Conclusion: SMART Arm training supported a clinically significant improvement in arm 
function, which was similar to usual therapy. All groups maintained gains at 12 months.  
Clinical trial registration information: Unique identifier: ACTRN12608000457347. URL: 
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83061. 
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Introduction 
Meaningful recovery of arm and hand function after stroke is a challenge for stroke survivors, 
as well as therapists 1-3. Over the last decade, our understanding of requirements for recovery 
4 and the number of interventions designed to promote recovery 5 have increased. Nonetheless, 
many stroke survivors continue to have severe upper limb disability early after stroke, which 
persists in the long term 1. While intensive and repetitive task-oriented practice is considered 
important for functional recovery 5, stroke survivors with little or no underlying movement 
have difficulty engaging in such practice 6. Consequently, training interventions specifically 
designed to enable stroke survivors with severe paresis to undertake task-oriented practice 
have emerged 7,8. SMART Arm training is one such intervention 9.  
The SMART Arm consists of a mechanical device interfaced with an interactive 
computer-training program that is combined with outcome-triggered electrical stimulation 
(OT-stim). It is designed to enable a stroke survivor with little or no muscle activity to reach 
in a straight-line path (Figure 1). The key mechanical component is a ‘track’ to which the 
hand is attached. Initially, the track makes reaching easier by minimizing resistance to 
movement and reducing mechanical degrees of freedom to be controlled. As the capability of 
the stroke survivor progresses, demands are increased through incremental additions of load, 
track inclination, elevation and orientation or relaxation of constraints (e.g. release of hand 
from splint to enable grasping). To enhance motor learning, the interactive computer-training 
program provides instruction, visual and auditory feedback, and progressive modification of 
training parameters (e.g. tapering of feedback). OT-stim is used to make reaching possible 
when a stroke survivor presents initially with negligible voluntary muscle activity. As the 
stroke survivor attempts to reach, and achieves the designated ‘outcome’ (e.g. their initial 
maximum active reach distance), electrical stimulation (ES) is triggered to augment reaching 
through full range. As capacity for independent movement increases, the ‘outcome’ (i.e. 
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distance reached) required to trigger the assisting ES is incrementally increased.  
The effectiveness of SMART Arm training has been demonstrated in two studies: a 
RCT in the community9 and a pilot RCT in an inpatient setting 10. Accordingly, changes in 
muscle activation patterns 11 and increases in corticospinal reactivity 12, that have 
accompanied increases in capacity to perform reaching movements, have exhibited some of 
the characteristics of ‘true’ recovery 13. The feasibility of SMART Arm training in the home 
with minimal supervision has also been demonstrated in a single case study14. 
The ultimate challenge for stroke survivors with severe upper limb paresis is to bridge 
the gap between no movement, and use of the arm in everyday tasks. To maximize the 
likelihood of this occurring, rehabilitation is typically offered in the first three to six months 
following stroke, when the brain is considered most responsive to rehabilitation 15-17 and 
when there are fewer secondary impairments, such as contractures 18 or pain 19. Ideally, the 
stroke survivor also has the opportunity to use their arm in everyday tasks relevant to their 
goals and lifestyle 20. Consistent with this rationale, the purpose of the present trial was to 
determine the efficacy of SMART Arm training early after stroke when used in combination 
with usual therapy. Our primary hypothesis was that SMART Arm training with or without 
OT-stim, combined with usual therapy – when compared to usual therapy alone – would lead 
to greater improvement in arm function in stroke survivors with severe upper limb disability 
undergoing inpatient rehabilitation. Our secondary hypothesis was that those who receive 
SMART Arm training with usual therapy - compared to those who received usual therapy 
alone, would achieve greater improvement in arm and hand function, fewer adaptive changes 
and greater use of the arm in everyday tasks after training and at 6 and 12 month follow-up.  
 
Methods 
Design 
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A prospective, multicentre, assessor-blinded, three-group, parallel-randomised controlled trial 
was undertaken: recruitment February 2010 to December 2012; follow-ups until December 
2013. Princess Alexandra Hospital Ethics Committee (Clearance ID: 2008-046) and The 
University of Queensland Medical Research Ethics Committee (Clearance ID: 2007001628) 
approved the study protocol, which was conducted in accordance with the Declaration of 
Helsinki. Written informed consent was obtained from all participants or their legal guardian. 
The protocol for this study was registered with the Australian and New Zealand Clinical 
Trials Registry (ACTRN12608000457347). Detailed description of study methods can be 
found in the published study protocol 21. 
Participants 
Consecutively admitted patients at trial sites were screened for eligibility by an independent 
research assistant. Trial sites included the Acute Stroke Unit or Geriatric and Rehabilitation 
Unit at Princess Alexandra Hospital and Queen Elizabeth II Jubilee Hospital in Brisbane, 
Australia. Patients were included if they were adult stroke survivors (≥18 years) with a 
primary diagnosis of first-ever unilateral stroke less than 4-months prior confirmed 
radiologically (CT or MRI) or clinically by the consulting physician; had severe upper limb 
disability demonstrated by a score of 3/6 or less on the Motor Assessment Scale (MAS) item 
6 (upper arm function) 22; and able to follow single stage commands. Patients were excluded 
if deemed medically unstable by a medical officer; had upper limb comorbidities that could 
limit function (e.g. arthritis); inability to tolerate (e.g., hypersensitivity) or contraindication to 
(e.g., pacemaker) cutaneous ES. 
Randomization protocol 
Physiotherapists and occupational therapists identified potential participants and notified the 
trial screener. After consent and initial assessment, participants were randomly allocated to 
one of three dose-matched groups (two intervention, one control), using random permuted 
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blocks of four or six in a 1:1 ratio. The allocation sequence was prepared using a computer 
generated random number sequence by an offsite investigator, who was not involved in 
recruitment, intervention or data collection. A set of consecutively numbered, sealed, opaque 
envelopes containing allocations was centrally generated for each hospital.   
Intervention 
Participants were randomly allocated to 60 mins/day, 5 days/week for 4 weeks of (1) SMART 
Arm with OT-stim and usual therapy, (2) SMART Arm alone and usual therapy, or (3) usual 
therapy. Volume of training was based on ‘usual’ time reportedly spent on upper limb therapy 
at each site. SMART Arm training was delivered in one session by one of five 
physiotherapists or occupational therapists, trained in operation of the SMART Arm. ‘Usual 
therapy’ was delivered and recorded in logbooks in a second session by hospital 
physiotherapy and occupational therapy staff. If a SMART Arm or usual therapy session (e.g. 
due to illness) was missed, additional days were added to ensure participants had the 
opportunity to engage in 20-days of therapy.  
The two SMART Arm groups participated in SMART Arm training according to the 
established training protocol10. Training sessions began with the participant seated in a chair 
beside the SMART Arm, restrained by a harness to restrict compensatory trunk movement. 
The affected arm was positioned in 90° elbow flexion, forearm mid pronation-supination and 
wrist mid extension- flexion in the functional position. The hand was placed in a splint 
connected to a manipulandum that was mounted on a linear slide that served to constrain 
movement to one plane and reduce resistance to movement. The slide was instrumented to 
measure displacement, for the purpose of providing continuous visual feedback to the 
participant. When prompted by an audible tone, the participant attempted to push their hand 
along the linear track to reach a pre-set goal. This goal was a horizontal target line 
superimposed on the visual display at a position that corresponded with the participant’s 
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maximum passive reaching distance established at session commencement. Participants were 
asked to perform a consistent minimum number of repetitions: 60 per day for week one and 
80 per day for weeks two through four. This dose was established in previous SMART Arm 
trials9,10. At the discretion of SMART Arm trainers, progression of training parameters 
occurred once consistent performance of reaching was achieved. Progressions recorded 
included repetitions, track inclination, degree of shoulder external rotation, hand position, 
load, visual and auditory instruction and feedback, (therapist) instruction and supervision. To 
ensure intervention fidelity and consistency between trainers, one researcher (KH) monitored 
participant training logbooks for dose and progression of training and accordingly, mentored 
trainers.  
Participants allocated to SMART Arm-stim received stimulation to lateral head of 
triceps via an Empi 300PV unit (St Paul, MN, USA) to augment full range reaching. 
Stimulation parameters consisted of a 1-second ascending ramp of 200-µs pulse width 
biphasic stimulation at 35Hz applied at a constant level. Stimulation was initiated once the 
participant reached their previously recorded ‘personal best’ displacement and ceased once 
they achieved the goal or after 8 seconds, a time period considered adequate to complete the 
task. Stimulation intensity was the maximum tolerated by the participant. When required, 
participants receiving SMART Arm alone were assisted, with therapist hands-on support, to 
augment full range reaching consistent with usual therapy.   
Usual therapy, which has been previously reported 10, included physiotherapy, 
occupational therapy and therapy assistant time, and involved a mix of one-on-one and group 
therapy sessions. Content of sessions was not standardized and included passive (e.g., 
stretching, cyclic ES), active (e.g., strengthening, modified task-oriented practice) and 
activities of daily living (e.g., dressing) interventions.  
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Outcome measures 
All participants were assessed at four time points: within three days prior to intervention 
commencement (baseline, 0-weeks) and after intervention completion (4-weeks), and within 
two weeks of 26- and 52-weeks follow-up. The primary outcome was post-intervention MAS 
item 6 (MAS6), upper arm function, measured on a scale from 0–6 with a higher score 
equating to better function. This measure has established reliability and validity within a 
stroke population 22 and sensitive to change in people with severe upper limb disability 
undertaking rehabilitation 23, and after SMART Arm training9,10,14. 
Secondary clinical outcome measures included impairment, activity and participation 
measures. Impairment measures included strength of lateral head of triceps brachii using 
Medical Research Council (MRC) manual muscle testing with ratings from 0–5 [29]; 
resistance to passive elbow extension using the modified Ashworth Scale 24; joint tenderness 
on passive movement of the hemiplegic shoulder using Ritchie Articular Index (RAI) 25. Arm 
activity was measured using MAS Items 6, 7 and 8 total score and Rasch Partial Credit Model 
26. Participation measures consisted of two self-report measures: Stroke Impact Scale (SIS) 27 
and Motor Activity Log-28 (MAL) 28. Secondary laboratory measures, included kinematics 
and kinetics of reaching and are to be reported separately.  
Demographic information collated from medical records included age, stroke onset 
date, stroke type (ischaemic or haemorrhagic) and stroke medical intervention (e.g. 
thrombolysis). Clinical measures to quantify presence of multiple impairments at baseline 
included the Cognitive Linguistic Quick Test 29; upper limb sensation using the Nottingham 
Sensory Assessment 30; and motor function using the MAL defined ROM measure 28 which 
included voluntary finger extension as a marker of a recovery potential 31. The SAFE Score 
was calculated retrospectively from the MAL defined ROM measure.  
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Sample size 
A priori power calculation was undertaken to determine sample size. Based on previous 
findings 9,10, mean improvement in MAS6 post training of 1.8 (SD 2) in the usual therapy 
group, 2.91 (SD 2) in SMART Arm alone group and 3.91 (SD 2) in SMART Arm 
with OT-stim group were estimated. To achieve 80% power, significance of 0.05 with 
pairwise comparisons and allowing for a 15% dropout rate, 25 subjects were required 
per group, totalling 75. 
 
Analysis 
Statistical analysis was performed using the intention-to-treat principle with a two-tailed α-
level of 0.05 (IBM SPSS v22.0, IBM Corp., Armonk, NY, USA). Descriptive statistics were 
used to ensure comparability between groups at baseline, and to test assumptions concerning 
use of parametric statistics. To determine differences in outcome between groups, generalized 
linear mixed effects models were used for interval data and mixed effects models for 
continuous data. Group, time and interaction between group and time were used as fixed 
factors and participants as a random factor. For the primary outcome measure, comparison 
was made between groups for change in MAS6 scores between baseline (0 weeks) and post-
training (4 weeks) and 95% confidence intervals for mean differences for pairwise 
comparisons were calculated. A 1-point (15%) change was adopted as a clinically important 
difference 32,33. Post hoc within group t-test was performed to detect a difference in MAS6 
improvement based on the presence or absence of voluntary finger extension at baseline. 
Generalised odds ratios (GenOR) were calculated at 4, 26 and 52 weeks to estimate the odds 
that an individual in a SMART Arm group would have a better outcome than the usual 
therapy group, potentially enabling greater use of their arm in everyday tasks. 34. Ties were 
split to avoid inflating the estimated odds ratio. Proportion of participants who showed an 
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improvement (increase in MAS6 score) compared to baseline were calculated at each post 
training time point. For secondary outcome measures, comparisons were made between 
groups between baseline and post-training (0 - 4 weeks), baseline and follow-up (0 – 26 
weeks; 0 - 52 weeks).  
 
Results 
Seven hundred and thirty-three individuals with stroke were admitted and assessed for 
eligibility with 50 stroke survivors with severe arm paresis (MAS6 < 4) consenting to 
participate. Recruitment ceased prior to reaching the estimated sample size of 75 as system 
resources could not support the study beyond the three year recruitment period. Random 
allocation resulted in 16 participants in the SMART Arm OT-stim group, 17 in the SMART 
Arm alone group and 17 the usual therapy group. Attrition rate was 6% after training, 22% at 
26 weeks and 30% at 52 weeks. Flow of participants is presented in Figure 1. At baseline 
there was heterogeneity across the sample, nonetheless demographic and clinical 
characteristics of each group were similar (Table 1) with evidence of severe and multiple 
impairments of motor, sensory and cognitive-linguistic function across all three groups. 
According to a SAFE score of < 4, all participants had severe upper limb impairment and 
most participants (78%) lacked voluntary finger extension with no difference between groups.  
 
Figure 1 about here 
Table 1 about here 
 
Compliance with training was high, with 90% of participants completing 85% or more 
training sessions, with no differences between groups. On average, usual therapy consisted of 
46 minutes of individual and 11 minutes of group therapy per participant, per day with a 
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higher dose (29 versus 17 minutes, P < 0.002) and a greater number (1218 versus 549) of 
minutes focused on impairment than activity level of function 35. There were no adverse 
events.  
Improvement in arm function (MAS6) was not significantly different between groups 
immediately post-training, or at 26 or 52 weeks follow-up (time x group) (P = .955). Raw 
scores at each measurement time point for each intervention group are in Table 2. Change 
scores within and between groups are in Table 3. Change in MAS6 was not significantly 
different between participants with or without voluntary finger extension within groups (P 
>.156) or across the entire sample (P =.461). At post-training, there were greater odds that a 
participant would have a higher MAS6 in the SMART Arm OT-stim compared to usual 
therapy group (GenOR = 1.47, 95% CI 1.23 to 1.71) with no difference between SMART 
Arm alone and usual therapy groups (GenOR = 0.80, CI 0.56 to 1.03) (Figure 2). At 26 weeks, 
there were greater odds that participants in the SMART Arm alone compared to the usual 
therapy group would have a higher MAS6 score (GenOR = 1.31, 95% CI 1.05 to 1.57), but 
not between the OT-stim and usual therapy groups (GenOR = 1.24, 95% CI 0.98 to 1.50). At 
12 months there were no differences between usual therapy and SMART Arm groups (OT-
stim: GenOR = 1.07, 95% CI 0.83 to 1.32, alone: GenOR = 0.88, 95% CI 0.64 to 1.88) 
(Figure 3). 
 
Table 2 about here 
Table 3 about here 
Figure 2 about here 
Figure 3 about here 
 
Improvement in arm function within all three intervention groups over time was 
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statistically (P  <.001) and clinically significant (≥ 1 improvement in MAS6) by post training 
(≥ 1) and 26 and 52 weeks (≥ 2).  In the SMART Arm OT-stim group, 65% of participants 
showed improvement in MAS6 compared to baseline that was sustained at 6 months (65%) 
but reduced to 53% at 12 months. In the SMART Arm alone group, 53% of participants 
improved in MAS6 at post training, rising to 79% at 6 months, and dropping to 58% at 12 
months. In the usual therapy group, 47% of participants improved in MAS6 at post-training, 
rising to and remaining steady at 59% at 6 and 12 months.  
Secondary outcome measures (Table 2 and 3) were not significantly different between 
intervention groups. All three groups showed a statistically and clinically significant 
improvement over time for triceps muscle strength (P < 0.001), MAS 678 (P < 0.001), MAL 
Amount (P < 0.001) and Quality of Movement (P < 0.001) and SIS Arm Recovery (P < 
0.001). No difference was found in the Modified Ashworth Scale or Ritchie Articular Index in 
any group at any measurement time-point indicating that pain and resistance to passive 
movement did not develop.  
 
Discussion 
This study assessed with respect to usual therapy alone, the effect on arm function of SMART 
Arm training, when used with and without OT-stim in combination with usual therapy, in 
stroke survivors with severe upper limb disability participating in inpatient rehabilitation. All 
groups exhibited higher levels of function following the training period, yet contrary to our 
hypothesis there were no differences in the degree of change between groups.  
The RCT design that required random allocation of participants to groups may have 
been sub-optimal for the individual. For example, OT-stim group participants trained with ES 
for the four full weeks. During this time, some participants were able to reach without 
requiring stimulation. Unnecessary stimulation could have reduced the challenge for 
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participants, and level of engagement and motivation required to progress optimally 36. 
Similarly, SMART Arm alone group participants with negligible movement may have taken 
longer to learn to reach than if they had first used ES to augment reaching. Observed patterns 
of improvement lend support to this proposition. Odds of SMART Arm OT-stim group 
participants making a moderate to large improvement were greatest post-training, but not 
sustained when post-training practice occurred without ES augmentation, revealed at 6-month 
follow-up. In contrast, those who trained without ES were more likely to make a moderate to 
large improvement at 6-months post training than immediately after training. A plausible 
explanation is that SMART Arm alone group participants were forced to ‘solve the movement 
problem’ 37 to reach successfully during SMART Arm training, and could subsequently apply 
this same strategy to practice of everyday tasks after training 38. The salient point is that even 
though the SMART Arm interactive training program is designed to provide for each stroke 
survivor a level of challenge that is tailored to their current capability 39, the RCT training 
protocol possibly limited the degree to which this objective was achieved. Furthermore, 
without a clear contrast in training between the two SMART Arm groups, it is possible that 
benefits of training were determined more by the extent to which the intervention matched 
participants’ ‘challenge point’, rather than by their allocated intervention. 
Our previous studies demonstrated benefits of SMART Arm training 9,10,14 yet the 
present study, showed no additional benefit over and above usual therapy. While the 
estimated sample size was not achieved due to recruitment delays, insufficient power (type II 
error) is an unlikely explanation, as there was no apparent trend towards group differences. To 
determine how to gain the ‘best effect’, training characteristics that optimise exploitation of 
recovery potential, and individual characteristics of stroke survivors that determine the likely 
degree of response, need to be considered.  
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In this current study, 20 hours of training over four weeks for stroke survivors with 
severe paresis was almost certainly too little practice, over too short a time period, to shift the 
recovery profile, above the spontaneous recovery profile 13,40-42. There is increasing evidence 
that the greatest opportunity for motor recovery after stroke occurs during the unique 
‘sensitive period’, in which time-enhanced spontaneous as well as intervention-mediated 
plasticity exists 13. As the ‘sensitive period’ is presumed to begin within two weeks after 
stroke and to continue for approximately three months40,42,43 greater spontaneous recovery 
may have occurred for participants who were earlier post stroke. For the full potential benefit 
of augmented recovery to be realized, training would have needed to commence within two 
weeks rather than on average, 39 days (SD26) post stroke and continued for up to three 
months, rather. Additionally, although comparable across the three intervention groups, 
variability observed in time post stroke could indicate that a larger sample size was required 
to demonstrate a significant difference between groups 31. Future research would need to 
control for time post stroke to mitigate the potential influence of this factor on study findings. 
With respect to training intensity, optimal dose is unknown 44 45. A recent systematic 
review suggests that a dose at least triple what is ‘usually provided’ is required to demonstrate 
a therapeutic benefit 41. In practical terms, the challenge is for stroke survivors to commence 
intensive practice within an acute setting, where many diagnostic and therapeutic 
interventions compete for their time, and to continue practice during the time in which 
inpatient and outpatient rehabilitation is typically available.  
Usual therapy (received by all participants) was of a high volume in this current study 
compared to previous studies 35. No consistent effort was made however, to relate goals of 
usual therapy to SMART Arm training, limiting potential for carryover for those who 
received both 46. In contrast, in a previous study when SMART Arm training occurred in the 
home environment, 14 the participant could directly link SMART Arm training with 
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purposeful real world use 47 and make highly meaningful gains for the effort 4. To tease out 
active ingredients 45 that may be critical when SMART Arm training is used in combination 
with usual therapy, a secondary analysis of training data is currently underway.  
Participants in this current study were comparable between groups in terms of time 
since stroke, severity of upper limb paresis and presence of cognitive, linguistic and /or 
sensory impairments. Presence of voluntary finger extension at baseline was uncommon, 
highlighting limitations of this measure as a marker of recovery potential in a severely 
impaired cohort 31. It is not known whether groups were comparable in terms of 
neurobiological reserve, as measures of residual brain function (e.g. motor-evoked potentials 
or structure (e.g., corticospinal tract asymmetry) were not obtained 48. Use of measures of 
brain reserve in future would allow prognostic stratification of participants, which in turn, 
may permit identification of stroke survivors with the greatest potential to achieve clinically 
meaningful improvements in arm function through SMART Arm training. For those with 
more limited neurobiological reserve, strategies to exploit their potential for partial recovery 
could be explored 49. 
Two alternative interventions that enable stroke survivors with severe paresis to 
engage in upper limb practice are robotic therapy and ES 50-52. Similar to SMART Arm, 
evidence of effectiveness of these interventions above usual therapy has been variable. A 
recent RCT 8 comparing robotic therapy and ES to usual therapy demonstrated no difference 
between groups while earlier systematic reviews demonstrated improvements in arm 
impairment following robotic therapy 53 and arm activity following ES 54. Participants in the 
current study had more severe motor impairments than participants typically selected for 
robotic therapy and ES studies 7,53,54 making comparison between interventions difficult. 
Encouragingly, all participants in the current study engaged in repetitive upper limb practice, 
despite presence of severe and multiple impairments across sensory, cognitive and / or 
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linguistic domains. Contrary to oft-held views 40,55 participants were able to demonstrate 
improvements in arm function that were maintained at 12 months follow-up 56.  
 
Implications 
To demonstrate the full recovery potential of SMART Arm training, future studies 
need to include prognostic stratification using measures of neurobiological reserve to identify 
those most likely to respond within the study period and to ensure prognostic comparability 
between intervention and control groups.  
To shift the recovery profile for stroke survivors with severe paresis, over and above 
the spontaneous recovery profile, consideration must be given to timing, dose and duration of 
training required to fully exploit the ‘sensitive period’ in which therapy-mediated recovery is 
heightened. In addition, SMART Arm training needs to be individualised to achieve the 
optimal challenge point, and to include real world use.  
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Table 1: Participant characteristics at baseline. SA-stim = SMART Arm with stimulation, SA-alone = SMART Arm alone, Usual = usual care 
 
SA-stim 
(n = 16) 
SA-alone 
(n = 17)  
Usual  
(n = 17) 
Age, years * 57.3 (13.5) 52.4 (15.6) 51.2 (15.0) 
Type of stroke, no. ischaemic/haemorrhagic 12/4 13/4 16/1 
Time since stroke at week = 0, days * 39.1 (24.7) 43.9 (21.7) 34.7 (31.2) 
Gender, no. male (%) 11 (69) 12 (71) 11 (65) 
Affected arm, no. left (%) 8 (50) 10 (59) 7 (41) 
Thombolysis, no. with tPA (%)  4 (25) 3 (18) 2 (12) 
Voluntary Finger Extension, yes/no 5/11 3/14 3/14 
Cognitive Linguistic Quick Scale, total score 1-4 ^ 3 (2-3) 3 (2-4) 4 (3-4) 
Nottingham Sensory Assessment, score 0-78 ^ 35 (19-65) 46 (15-64) 56 (41-66) 
Motor assessment scale (MAS)    
  MAS-1, supine to side lying, score 0-6 ^ 2 (1-3) 2 (1-3) 2 (1-3) 
  MAS-2, supine to sit, score 0-6 ^ 3 (3-6) 4 (3-6) 4 (3-6) 
  MAS-3, sitting balance, score 0-6 ^ 2 (1-3) 3 (2-4) 2 (2-3) 
  MAS-4, sit to stand, score 0-6 ^ 2 (1-2) 2 (1-2) 1 (1-2) 
  MAS-5, walking, score 0-6 ^ 0 (0-1) 0 (0-2) 0 (0-0) 
  MAS-6, upper arm function, score 0-6 ^ 1 (0-1) 0 (0-1) 0 (0-1) 
  MAS-7, hand movements, score 0-6 ^ 0 (0-0) 0 (0-0) 0 (0-0) 
  MAS-8, advanced hand activities, score 0-6 ^ 0 (0-0) 0 (0-0) 0 (0-0) 
^ Median (interquartile range)  *Mean (standard deviation)  # Higher score denotes greater impairment. 
 
  
Table 2. Median (IQR) or mean (SD) at each time point by group. SA-stim = SMART Arm with stimulation, SA-alone = SMART Arm alone, Usual = usual care 
 Week 0 Week 4 Week 26 Week 52 
 SA-stim 
(n = 16) 
SA-alone 
(n = 17) 
Usual 
(n = 17) 
SA-stim 
(n = 14) 
SA-alone 
(n = 17) 
Usual 
(n = 16) 
SA-stim 
(n = 12) 
SA-alone 
(n = 16) 
Usual 
(n = 11) 
SA-stim 
(n = 12) 
SA-alone 
(n = 13) 
Usual 
(n = 10) 
MAS-6 
(score,0-6) 
1 
(0–1) 
0 
(0–1) 
1 
(0–1) 
1 
(1-5) 
1 
(0-3) 
1 
(0-3) 
3 
(1-5) 
3 
(0-5) 
4 
(1-5) 
4 
(0-5) 
1 
(0-5) 
3 
(0-5) 
MAS-6,7,8  
(Sum, 0-18) 
1 
(2) 
0 
(0-1) 
0 
(2) 
1 
(1-14) 
1 
(0-4) 
3 
(5) 
4 
(1-13) 
2.5 
(0-13) 
6 
(5) 
7.5 
(1-15) 
1 
(0-13) 
5 
(6) 
Modified Ashworth  
(scale, 0-4)# 
1  
(0-2) 
1  
(0-2) 
0  
(0-1) 
1  
(0-2) 
0 
(0 – 2) 
1 
(0-1) 
1  
(0-2) 
1  
(0-2) 
1 
(0-1) 
2 
(0 – 3) 
0 
(0 – 3) 
1 
(0-1) 
Triceps strength 
(grade, 0-5) 
3-  
(1+-3+) 
2  
(0-3+) 
2-  
(0-3+) 
3+ 
(2+-4+) 
3 
(2 – 4+) 
2+ 
(1+ - 5) 
4 
(2 – 4+) 
4  
(2+- 4+) 
4 –  
(2 – 5) 
3 
(2+- 4+) 
4 
(2+- 4+) 
4- 
(3 – 5) 
Ritchie Articular 
Index(score, 0-3)# 
0  
(0-1) 
0  
(0-1) 
0  
(0-1) 
0 
(0-1) 
0  
(0-1) 
0  
(0-1) 
0  
(0-1) 
0  
(0-1) 
0  
(0-1) 
0  
(0-1) 
0  
(0-1) 
0  
(0-1) 
SIS Arm recovery 
(0-100%) 
20  
(19) 
18  
(17) 
16  
(14) 
48 
(26) 
27 
(16) 
29  
(22) 
57  
(14) 
47  
(25) 
57  
(14) 
53 
(26) 
39  
(27) 
48 
(19) 
SIS Total recovery 
(0-100%) 
34  
(20) 
41  
(20) 
30  
(20) 
58 
(24) 
45 
(20) 
43  
(22) 
57  
(13) 
47  
(25) 
57  
(14) 
59 
(17) 
48  
(29) 
63 
(18) 
 MAL quality  1 0  5 26 5 13 32 26 24 36 20 30 
  
(0 – 140) 
 
(3) (0) (15) (41) (7) (29) (40) (35) (26) (40) (28) (35) 
MAL amount  
(0 – 140) 
0 
(1) 
0  
(0) 
5 
(14) 
26 
(41) 
4 
(7) 
13 
(23) 
32 
(44) 
26 
(37) 
26 
(28) 
36 
(42) 
20 
(28) 
31 
(35) 
Abbreviations: SA-stim (Smart Arm with outcome-triggered stimulation); SA alone (SMART Arm alone); UT (Usual Therapy); MAS6,7,8 Motor Assessment Upper Limb 
summative score; SIS (Stroke Impact Scale; MAL (Motor Activity Log). 
# Higher score denotes greater impairment 
  
Table 3. Within group differences (means and SD) and between group differences (mean difference and 95% confidence intervals)   
 
  Within group differences Between group differences 
 Week 4 – Week 0 Week 26 – Week 0 Week 52 – Week 0 Week 4 - 0 Week 26 - 0 Week 52 - 0 
 SA 
-stim 
SA-
alone 
UT SA- 
stim 
SA- 
alone 
UT SA- 
stim 
SA- 
alone 
UT SA-stim   
- UT 
SA-alone 
- UT 
SA-stim  
- UT 
SA-alone  
- UT 
SA-stim  - 
- UT 
SA-alone 
- UT 
MAS-6 
(score,0-6) 
2 
(2) 
1 
(1) 
1 
(1) 
2 
(2) 
2 
(2) 
3 
(1) 
2 
(2) 
2 
(2) 
2 
(1) 
0 
(-1 to 2) 
0 
(-1 to 2) 
1 
(-1 to 2) 
0 
(-1 to 2) 
0 
(-2 to 2) 
1 
(-1 to 2) 
MAS-6,7,8 
Total sum  
(score,0-18) 
5 
(6) 
2 
(3) 
3 
(5) 
1 
(3) 
3 
(4) 
1 
(2) 
1 
(1) 
0 
(1) 
0 
(2) 
 
2 
(-2 to 6) 
1 
(-2 to 4) 
0 
(-4 to 5) 
0 
(-4 to 5) 
1 
(-4 to 6) 
1 
(-4 to 7) 
Modified 
Ashworth  
(scale,0-4)# 
0 
(1) 
0 
(1) 
0 
(1) 
0 
(2) 
0 
(1) 
0 
(1) 
1 
(1) 
0 
(1) 
0 
(1) 
0 
(-1 to 1) 
0 
(-1 to 1) 
0 
(-1 to 1) 
0 
(0 to 1) 
0 
(-1 to 2) 
0 
  (-1 to 1) 
Triceps 
strength 
(grade, 0-5) 
3 
(4) 
3 
(3) 
3 
(5) 
2 
(2) 
2 
(3) 
-1 
(4) 
-1 
(2) 
-1 
(2) 
2 
(3) 
0 
(-3 to 3) 
0 
(-2 to 2) 
1 
(-2 to 5) 
1 
(-2 to 5) 
1 
(-2 to 4) 
0 
(-3 to 4) 
  
Ritchie 
Articular 
Index 
(score, 0-3)# 
0 
(1) 
0 
(1) 
0 
(1) 
0 
(1) 
0 
(1) 
0 
(1) 
0 
(1) 
0 
(1) 
0 
(1) 
0 
(-1 to 1) 
0 
(-1 to 1) 
1 
(0 to 1) 
1 
(0 to 1) 
1 
(0 to 2) 
1 
(0 to 1) 
Arm recovery 
SIS self report 
(0-100%) 
27 
(24) 
9 
(22) 
13 
(21) 
1 
(1) 
8 
(23) 
22 
(20) 
-3 
(28) 
-11 
(24) 
-7 
(15) 
15 
(-3 to 32) 
4 
(-12to 20) 
4 
(-16 to 23) 
7 
(-15 to 30) 
1 
(-20to 23) 
7 
(-20to 33) 
Total 
recovery 
SIS self report 
(0-100%) 
23 
(27) 
5 
(27) 
13 
(25) 
-2 
(21) 
1 
(27) 
12 
(20) 
2 
(17) 
-2 
(19) 
9 
(13) 
10 
(-10 to 30) 
-8 
(-10to 27) 
2 
(-20 to 24) 
16 
(-10 to 42) 
8 
(10 to 26) 
27 
(-1 to 55) 
MAL quality  
(score, 0-140) 
25 
(41) 
5 
(7) 
10 
(18) 
13 
(16) 
21 
(29) 
6 
(26) 
4 
(14) 
-5 
(13) 
6 
(23) 
15 
(-9 to 38) 
5 
(-5 to 15) 
11 
(-18 to 41) 
6 
(-20 to 32) 
11 
(-20to 41) 
4 
(-18to 27) 
MAL amount  
(score, 0-140) 
26 
(41) 
4 
(7) 
9 
(15) 
12 
(17) 
21 
(31) 
10 
(16) 
4 
(11) 
-4 
(10) 
4 
(18) 
17 
(-6 to 39) 
5 
(-3 to 13) 
10 
(-22 to 41) 
4 
(-22 to 31) 
0 
(-13to 13) 
-9 
(-22to 41) 
Abbreviations: SA-stim (Smart Arm with outcome-triggered stimulation); SA alone (SMART Arm alone); UT (Usual Therapy); MAS6,7,8 Motor Assessment Upper Limb 
summative score; SIS (Stroke Impact Scale; MAL (Motor Activity Log). # Higher score denotes greater impairment.  



